$GTHX
G1 Therapeutics Inc
PRICE
$3.21 ▲3.215%
Last Close
VOLUME
440,514
DAY RANGE
2.933 - 3.4
52 WEEK
1.08 - 5
Key Metrics
Market Cap
167.56 M
Beta
2.23
Avg. Volume
1.20 M
Shares Outstanding
52.20 M
Yield
0%
Public Float
0
Next Earnings Date
2024-05-01
Next Dividend Date
Company Information
g1 therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology. the company is leveraging its proprietary kinase drug discovery platform to advance a pipeline of best-in-class compounds and first-in-class drug candidates.
CEO: Mark Velleca
Website: http://www.g1therapeutics.com/
HQ: 700 Park Offices Drive Research Triangle Park, 27709 North Carolina
Related News